PB RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2005) 29: 98-100. doi: 10.1192/pb.29.3.98
© 2005 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glover, K. J.
Right arrow Articles by Lawley, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Glover, K. J.
Right arrow Articles by Lawley, D.
Psychiatric Bulletin (2005) 29: 98-100
© 2005 The Royal College of Psychiatrists

How safe is lithium prescribing? Audit of a local prescribing framework and patient survey

Katherine J. Glover, Specialist Registrar in Old Age Psychiatry

Fieldhead Hospital, Ouchthorpe Lane, Wakefield, West Yorkshire WF13SP

David Lawley, Consultant Psychiatrist

Hull & East Riding Community Health NHS Trust, Hull

Declaration of interest

None.

AIMS AND METHOD

To examine the standards of lithium monitoring in eastern Hull following the introduction of a local prescribing framework, we investigated the biochemistry records of patients currently prescribed lithium, identified from primary care computerised records. A survey of patients’ knowledge about lithium therapy was also conducted.

RESULTS

Inadequate standards of lithium monitoring were demonstrated, with only 50% of patients having a level recorded during the preceding 3 months. Monitoring of thyroid and renal function was better, with two-thirds of patients tested in the past year. Patients’ knowledge of the side-effects and risks of lithium was minimal; only 7 out of 27 patients questioned felt able to identify the signs of lithium toxicity; three-quarters of those surveyed felt they had not been given enough information about their medication.

CLINICAL IMPLICATIONS

The introduction of prescribing frameworks or other guidelines does not ensure good practice. Further actions may be needed to ensure lithium is prescribed safely, such as patient registers, monitoring cards and automatic recall systems. Education of patients and primary care staff about the safe use of psychotropic drugs needs to be an ongoing process.




This article has been cited by other articles:


Home page
Qual Saf Health CareHome page
I. D Maidment, P. Lelliott, and C. Paton
Medication errors in mental healthcare: a systematic review
Qual. Saf. Health Care, December 1, 2006; 15(6): 409 - 413.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2005 The Royal College of Psychiatrists.